Skip to main content
BrainCited

Taurine 관련 산화 스트레스 및 신경염증

C 근거 소규모 연구에서의 근거는 제한적이지만, 일부 긍정적인 신호가 존재합니다.

Research suggests taurine's anti-excitotoxic effects and neuronal calcium homeostasis support may help protect against oxidative neuronal damage. Preclinical evidence is strong; human cognitive trials are limited.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dtaurine\u0026condition\u003Doxidative\u002Dneuroinflammation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

결론

Research suggests taurine's anti-excitotoxic effects and neuronal calcium homeostasis support may help protect against oxidative neuronal damage. Preclinical evidence is strong; human cognitive trials are limited.

Key Study Findings

Review
Taurine as an Early-Phase Disease-Modifying Candidate for Alzheimer's Disease.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: narrative review of taurine neuroprotective actions in Alzheimer's disease

Other
Ultramicronized palmitoylethanolamide restores astrocyte-neuron metabolic coupling and Klotho/FGF21 signaling in a triple-transgenic mouse model of …
Dose: None vs: untreated 3xTg-AD mice Outcome: metabolic coupling restoration (lactate-glutamate dynamics, taurine metabolism) 효과: None None

대상 집단: 6- and 12-month-old triple transgenic (3xTg-AD) Alzheimer's disease mice

Controlled Clinical Trial 6 weeks
Subchronic Residual Oil Fly Ash (ROFA) exposure induces oxidative stress in brain, lung, and cardiac …
Dose: 400 mg/kg/day vs: ROFA exposure without taurine Outcome: Multi-organ oxidative stress and neuroinflammation 효과: None None

대상 집단: Male Wistar rats with intranasal ROFA exposure

Other n=70
Synergetic effect of taurine/taurine nanoparticles along with Sinemet® against rotenone-induced Parkinson's disease in mice.
Dose: None vs: Rotenone-induced PD model controls Outcome: Neuroprotection in rotenone-induced PD mice 효과: None None

대상 집단: Rotenone-induced Parkinson's disease mice (10 groups)

Other
Taurine ameliorates viral encephalitis by restoring PRKN-mediated mitophagy.
Dose: None vs: HSV-1 infected cells/mice without taurine Outcome: HSV-1 infection and viral encephalitis severity 효과: None None

대상 집단: HSV-1 viral encephalitis in vitro and mouse model

Other 4 weeks
Taurine suppresses Aβ aggregation and attenuates Alzheimer's disease pathologies in 5XFAD mice and patient-derived cerebral …
Dose: 1000 mg/kg oral for 4 weeks vs: Vehicle control in 5XFAD mice Outcome: Aβ accumulation, tau phosphorylation, neuroinflammation 효과: None None

대상 집단: 5XFAD AD mice and patient-derived cerebral organoids

Key Statistics

6

연구

300

참여자

Positive

C

등급

Referenced Papers

NPJ Parkinson's disease 2024 57 인용
Frontiers in bioscience … 2015 62 인용
British journal of … 2014 111 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
500-2,000 mg/day
cognitivesupport:
1,000-3,000 mg/day

상한량: 3,000 mg/day (EFSA safety assessment)

연구에서 사용된 용량

용량 기간 효과 N
None -- Positive --
None -- Positive --
400 mg/kg/day 6 weeks Mixed --
None -- Positive 70
None -- Positive --
1000 mg/kg oral for 4 weeks 4 weeks Positive --
None -- Mixed --
None -- Mixed --

권장 복용 시간: With or without food; may be calming if taken evening

Safety & Side Effects

보고된 부작용

  • Generally very well-tolerated
  • Mild gastrointestinal discomfort (rare)
  • Drowsiness at high doses

알려진 상호작용

  • Antihypertensive drugs (additive blood pressure lowering)
  • Antiepileptic drugs (may enhance GABA effects)

일일 최대 섭취 허용량: 3,000 mg/day (EFSA safety assessment)

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Taurine help with 산화 스트레스 및 신경염증?
Based on 6 studies with 300 participants, there is limited but promising evidence that Taurine may support 산화 스트레스 및 신경염증 management. Our evidence grade is C (Some Evidence).
How much Taurine should I take for 산화 스트레스 및 신경염증?
Studies have used various dosages. A commonly studied range is 500-2,000 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Taurine?
Reported side effects may include Generally very well-tolerated, Mild gastrointestinal discomfort (rare), Drowsiness at high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Taurine and 산화 스트레스 및 신경염증?
We rate the evidence as Grade C (Some Evidence). This rating is based on 6 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

References

  1. [1] Muhammad Kamal Hossain et al.. Int J Mol Sci. 2026. Taurine as an Early-Phase Disease-Modifying Candidate for Alzheimer's Disease. doi:10.3390/ijms27041871 PubMed
  2. [2] Roberta Facchinetti et al.. Biomed Pharmacother. 2026. Ultramicronized palmitoylethanolamide restores astrocyte-neuron metabolic coupling and Klotho/FGF21 signaling in a triple-transgenic mouse model of Alzheimer's disease. doi:10.1016/j.biopha.2025.118965 PubMed
  3. [3] Xiaowei Song et al.. J Adv Res. 2025. Inhibition of mitophagy via the EIF2S1-ATF4-PRKN pathway contributes to viral encephalitis. doi:10.1016/j.jare.2024.08.003 PubMed
  4. [4] Ahmad Raza et al.. Metab Brain Dis. 2025. From metabolic dysregulation to neurodegenerative pathology: the role of hyperglycemia, oxidative stress, and blood-brain barrier breakdown in T2D-driven Alzheimer's disease. doi:10.1007/s11011-025-01700-z PubMed
  5. [5] Seyed Mehrad Razavi et al.. Metab Brain Dis. 2025. The effects of ursodeoxycholic acid on Parkinson's disease, a mechanistic review of the recent evidence. doi:10.1007/s11011-025-01542-9 PubMed
  6. [6] Apeksha Rana et al.. Front Nutr. 2025. Natural sulfur compounds in mental health and neurological disorders: insights from observational and intervention studies. doi:10.3389/fnut.2025.1534000 PubMed
  7. [7] Wanying Zhai et al.. Asian Pac J Allergy Immunol. 2025. Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness research. doi:10.12932/AP-100223-1542 PubMed
  8. [8] Meiling Yao et al.. Inflammation. 2025. LncRNA Tug1 Regulates Post-Stroke Microglial Pyroptosis via PINK1/Parkin-Mediated Mitophagy. doi:10.1007/s10753-024-02219-8 PubMed
  9. [9] Xiaowei Song et al.. Autophagy. 2025. Taurine ameliorates viral encephalitis by restoring PRKN-mediated mitophagy. doi:10.1080/15548627.2025.2538767 PubMed
  10. [10] Haixia Wang et al.. Phytomedicine. 2025. Daidzein alleviates chronic restraint stress-induced depression-like behavior by regulating neuroinflammation and synaptic plasticity via microbiota-gut-brain axis. doi:10.1016/j.phymed.2025.157394 PubMed
  11. [11] Hyewon Lee et al.. Biomed Pharmacother. 2025. Taurine suppresses Aβ aggregation and attenuates Alzheimer's disease pathologies in 5XFAD mice and patient-derived cerebral organoids. doi:10.1016/j.biopha.2025.118527 PubMed
  12. [12] Sung Min Moon et al.. Arch Pharm Res. 2025. Neuroprotective effects of taurine in a rodent model of parkinson's disease involve modulating astrocyte-mediated inflammation. doi:10.1007/s12272-025-01563-z PubMed
  13. [13] Doha M Beltagy et al.. Toxicol Mech Methods. 2025. Neuroprotective impacts of taurine nanoparticles against rotenone induced Parkinson's disease in mice. doi:10.1080/15376516.2025.2547874 PubMed
  14. [14] Bin Li et al.. Psychoneuroendocrinology. 2025. Transcriptomics study of hippocampus in mice exposed to heat stress. doi:10.1016/j.psyneuen.2025.107279 PubMed
  15. [15] Christina M Tognoni et al.. Res Sq. 2025. Protection of multiple aspects of Alzheimer's disease pathology using dietary supplementation with taurine. doi:10.21203/rs.3.rs-7483320/v1 PubMed
  16. [16] Alexander Shtilbans. J Nutr. 2025. Combination Supplement Therapy: A New Frontier in Treatment of Neurodegenerative Diseases. doi:10.1016/j.tjnut.2025.07.004 PubMed
  17. [17] Khaled M Elgindy et al.. Toxicol Res (Camb). 2025. Synergetic effect of taurine/taurine nanoparticles along with Sinemet® against rotenone-induced Parkinson's disease in mice. doi:10.1093/toxres/tfaf181 PubMed
  18. [18] Gedaias Noronha da Silva et al.. Neurotoxicology. 2025. Subchronic Residual Oil Fly Ash (ROFA) exposure induces oxidative stress in brain, lung, and cardiac tissues and promotes neuroinflammation, with … doi:10.1016/j.neuro.2025.103347 PubMed
  19. [19] Dayoon Kwon et al.. NPJ Parkinsons Dis. 2024. Diet and the gut microbiome in patients with Parkinson's disease. doi:10.1038/s41531-024-00681-7 PubMed
  20. [20] Shuang Chen et al.. J Neuroinflammation. 2024. Hypochlorous acid derived from microglial myeloperoxidase could mediate high-mobility group box 1 release from neurons to amplify brain damage in … doi:10.1186/s12974-023-02991-8 PubMed
  21. [21] Fernanda Huf et al.. Mol Cell Biochem. 2024. Neuroprotection elicited by taurine in sporadic Alzheimer-like disease: benefits on memory and control of neuroinflammation in the hippocampus of rats. doi:10.1007/s11010-023-04872-3 PubMed
  22. [22] Williams Kobik et al.. PLoS One. 2024. Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors. doi:10.1371/journal.pone.0289391 PubMed
  23. [23] Bin Li et al.. Int Immunopharmacol. 2024. Protective effects of taurine on heat Stress-Induced cognitive impairment through Npas4 and Lcn2. doi:10.1016/j.intimp.2024.113376 PubMed
  24. [24] Cyriac Abby Philips. Front Med (Lausanne). 2024. Commonly encountered symptoms and their management in patients with cirrhosis. doi:10.3389/fmed.2024.1442525 PubMed
  25. [25] Yanling Li et al.. Aging (Albany NY). 2024. Jingfang granules protects against intracerebral hemorrhage by inhibiting neuroinflammation and protecting blood-brain barrier damage. doi:10.18632/aging.205854 PubMed
  26. [26] Samar F Darwish et al.. Front Aging. 2023. The dual face of microglia (M1/M2) as a potential target in the protective effect of nutraceuticals against neurodegenerative diseases. doi:10.3389/fragi.2023.1231706 PubMed
  27. [27] Xueqi Wang et al.. Food Funct. 2023. Transcriptomic and metabolomic analyses provide insights into the attenuation of neuroinflammation by nervonic acid in MPTP-stimulated PD model mice. doi:10.1039/d2fo02595g PubMed
  28. [28] Fu-Chao Liu et al.. BMC Geriatr. 2023. Exploring the aging process of cognitively healthy adults by analyzing cerebrospinal fluid metabolomics using liquid chromatography-tandem mass spectrometry. doi:10.1186/s12877-023-03939-6 PubMed
  29. [29] Dan-Dan Wu et al.. Chem Biodivers. 2023. UHPLC-Orbitrap-Fusion-TMS-Based Metabolomics Study of Phenylpropionamides in the Seed of Cannabis sativa L. against Alzheimer's Disease. doi:10.1002/cbdv.202201047 PubMed
  30. [30] Zhuan Lv et al.. Front Endocrinol (Lausanne). 2022. Acupuncture ameliorates breast cancer-related fatigue by regulating the gut microbiota-gut-brain axis. doi:10.3389/fendo.2022.921119 PubMed
  31. [31] Wouter Claeys et al.. Sci Rep. 2022. A mouse model of hepatic encephalopathy: bile duct ligation induces brain ammonia overload, glial cell activation and neuroinflammation. doi:10.1038/s41598-022-22423-6 PubMed
  32. [32] David Scieszka et al.. Toxicol Sci. 2022. Neuroinflammatory and Neurometabolomic Consequences From Inhaled Wildfire Smoke-Derived Particulate Matter in the Western United States. doi:10.1093/toxsci/kfab147 PubMed
  33. [33] Samara P Silva et al.. J Immunol Res. 2021. Neuroprotective Effect of Taurine against Cell Death, Glial Changes, and Neuronal Loss in the Cerebellum of Rats Exposed to Chronic-Recurrent … doi:10.1155/2021/7497185 PubMed
  34. [34] Jason J Paris et al.. Geroscience. 2021. In vivo proton magnetic resonance spectroscopy detection of metabolite abnormalities in aged Tat-transgenic mouse brain. doi:10.1007/s11357-021-00354-w PubMed
  35. [35] Kaihua Zhai et al.. Hum Gene Ther. 2020. Long-Noncoding RNA TUG1 Promotes Parkinson's Disease via Modulating MiR-152-3p/PTEN Pathway. doi:10.1089/hum.2020.106 PubMed
  36. [36] Mujtaba Aamir Bhat et al.. Biomolecules. 2020. Expedition into Taurine Biology: Structural Insights and Therapeutic Perspective of Taurine in Neurodegenerative Diseases. doi:10.3390/biom10060863 PubMed
  37. [37] Chaoran Chen et al.. Life Sci. 2019. Roles of taurine in cognitive function of physiology, pathologies and toxication. doi:10.1016/j.lfs.2019.116584 PubMed
  38. [38] Hengli Zhao et al.. Amino Acids. 2018. Taurine supplementation reduces neuroinflammation and protects against white matter injury after intracerebral hemorrhage in rats. doi:10.1007/s00726-017-2529-8 PubMed
  39. [39] Aisling Chaney et al.. J Neurochem. 2018. Longitudinal investigation of neuroinflammation and metabolite profiles in the APPswe ×PS1Δe9 transgenic mouse model of Alzheimer's disease. doi:10.1111/jnc.14251 PubMed
  40. [40] Greice Caletti et al.. Amino Acids. 2018. Taurine counteracts the neurotoxic effects of streptozotocin-induced diabetes in rats. doi:10.1007/s00726-017-2495-1 PubMed
  41. [41] K H Reeta et al.. Neurochem Int. 2017. Chronic treatment with taurine after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress, cholinergic functions and … doi:10.1016/j.neuint.2017.03.006 PubMed
  42. [42] Kirk J Brower. Alcohol. 2015. Assessment and treatment of insomnia in adult patients with alcohol use disorders. doi:10.1016/j.alcohol.2014.12.003 PubMed
  43. [43] Roberta J Ward et al.. Front Biosci (Schol Ed). 2015. Ageing, neuroinflammation and neurodegeneration. doi:10.2741/S433 PubMed
  44. [44] Nicola J Kalk et al.. Br J Clin Pharmacol. 2014. The clinical pharmacology of acamprosate. doi:10.1111/bcp.12070 PubMed
  45. [45] Can Ali Agca et al.. Food Chem Toxicol. 2014. Taurine ameliorates neuropathy via regulating NF-κB and Nrf2/HO-1 signaling cascades in diabetic rats. doi:10.1016/j.fct.2014.05.023 PubMed

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.